IRVINE – October 27, 2026 -- SBC Medical Group Holdings (Nasdaq: SBC) will put its AI-driven longevity strategy in front of Asian investors this month, with CFO and COO Yuya Yoshida presenting at Cantor Fitzgerald Hong Kong's inaugural Asia Longevity Forum on October 26, followed by investor meetings on October 27 and a non-deal roadshow on October 28.
Yoshida takes keynote and panel slots at a forum with more than 40 companies
The two-day Cantor HK Asia Longevity Forum 2026 runs October 26-27 at The Murray Hotel in Central, Hong Kong. More than 40 public and private companies are expected to attend. Yoshida will speak in the keynote and panel sessions on day one. Forum themes include the longevity economy, AI and digital health adoption, and building Asia's next-generation healthcare system.
On October 27, SBC Medical will hold one-on-one meetings with investors attending the forum. The non-deal roadshow with investors in Hong Kong follows on October 28.
SBC AI Longevity Innovation, founded July 1, 2026, anchors the pitch
Yoshida is also President and Representative Director of SBC AI Longevity Innovation Inc. (SALI), a Tokyo-based operating company established in July 2026. SALI combines clinical knowledge and data from SBC Medical's clinic network with AI technology. Its stated aim is to create new value in longevity and to run clinic operations and the customer experience on an AI-native basis.
SALI will first develop and deploy products within the group. After the "SBC AI Assistant," the pipeline includes the "AI Preceptor" for staff training support, AI-enabled call center support, and data solutions for longevity medicine. In the longer term, SALI intends to offer its development and operational expertise to other medical institutions and healthcare-related businesses.
SBC Medical will publish the presentation materials for the forum on its investor relations website.